Home > National Drug Code (NDC) > Lotensin HCT

Lotensin HCT - 54868-5313-0 - (benazepril hydrochloride and hydrochlorothiazide)

Alphabetical Index


Drug Information of Lotensin HCT

Product NDC: 54868-5313
Proprietary Name: Lotensin HCT
Non Proprietary Name: benazepril hydrochloride and hydrochlorothiazide
Active Ingredient(s): 20; 25    mg/1; mg/1 & nbsp;   benazepril hydrochloride and hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Lotensin HCT

Product NDC: 54868-5313
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020033
Marketing Category: NDA
Start Marketing Date: 20050523

Package Information of Lotensin HCT

Package NDC: 54868-5313-0
Package Description: 30 TABLET in 1 BOTTLE (54868-5313-0)

NDC Information of Lotensin HCT

NDC Code 54868-5313-0
Proprietary Name Lotensin HCT
Package Description 30 TABLET in 1 BOTTLE (54868-5313-0)
Product NDC 54868-5313
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name benazepril hydrochloride and hydrochlorothiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20050523
Marketing Category Name NDA
Labeler Name Physicians Total Care, Inc.
Substance Name BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
Strength Number 20; 25
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Lotensin HCT


General Information